Last week's announcement from Astra Zeneca of 6000 job cuts globally, including 300 at UK Alderley Edge site is another signal of deep changes affecting the Pharma sector. But it isn't the end of Big Pharma as some have prematurely announced. It is another step in the decline of Old Pharma and the old 'Big Pharma' model of Drug Discovery. [read more]

The Prime Minister’s speech this afternoon announcing a Strategy for UK Life Sciences is an important step in defining a new role for Britain in the global fight against disease.

Bringing together business, researchers, clinicians and patients to translate discovery into clinical use for medical innovation within the NHS, the policy aims to radically empower patients, giving them earlier access to innovative treatments and the opportunity to take part in clinical trials. [read more]